Indica Labs Announces Informational Brochure on Lung Macrodissect AI
Learn more about Indica Labs and their Lung Macrodissect tool in this informational brochure.
The Lung Macrodissect AI tool from Indica Labs quantifies tumor content to facilitate downstream molecular testing in cases of NSCLC, helping labs increase the quality of test results, streamline workflows, and save resources, all while ensuring transparency with an auditable workflow. Check out the new brochure for more details about the comprehensive workflow for macrodissection, from key output metrics to clinical validation and available integration with Xyall’s Tissector automated macrodissection platform!
Lung Macrodissect AI is not a medical device in the EU/UK and is not intended to be used for diagnostic purposes. Lung Macrodissect AI is accessed via the HALO AP® enterprise digital pathology platform. Lung Macrodissect AI is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use.
HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR.
SOURCE: Indica Labs
